1. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, Baez J, Kochi A, Dye C, Raviglione MC. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA. 2000. 283:2537–2545.
2. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. Geneva: World Health Organization;(WHO/HTM/TB/2007.376).
3. Smith B, Ryan MA, Gray GC, Polonsky JM, Trump DH. Tuberculosis infection among young adults enlisting in the United States Navy. Int J Epidemiol. 2002. 31:934–939.
Article
4. Ciftci F, Tozkoparan E, Deniz O, Bozkanat E, Kibaroglu E, Demirci N. The incidence of tuberculosis in the armed forces: a good reflection of the whole population. Int J Tuberc Lung Dis. 2004. 8:965–968.
5. Kang CI, Choi CM, Kim DH, Kim CH, Lee DJ, Kim HB, Kim NJ, Oh MD, Choe KW. Pulmonary tuberculosis in young Korean soldiers: incidence, drug resistance and treatment outcomes. Int J Tuberc Lung Dis. 2006. 10:970–974.
6. Seung KJ, Bai GH, Kim SJ, Lew WJ, Park SK, Kim JY. The treatment of tuberculosis in South Korea. Int J Tuberc Lung Dis. 2003. 7:912–919.
7. Ji SH, Kim HJ, Choi CM. Management of tuberculosis outbreak in a small military unit following the Korean national guideline. Tuberc Respir Dis. 2007. 62:5–10.
Article
8. Joh JS, Lee CH, Lee JE, Park YK, Bai GH, Kim EC, Han SK, Shim YS, Yim JJ. The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results. J Korean Med Sci. 2007. 22:26–29.
Article
9. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med. 2000. 161:1376–1395.
10. Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, Lee JK, Kim SJ. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis. 2007. 11:571–576.
11. Wayne LG. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis. 1974. 109:147–151.
12. Centers for Disease Control (CDC). Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep. 1991. 40:585–591.
13. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993. 328:521–526.
Article
14. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, Kuznetznov S, Gusarova G, Zakharova S, Melentyev A, Krukova E, Golishevskaya V, Erokhin V, Dorozhkova I, Drobniewski F. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax. 2005. 60:130–135.
Article
15. Choi JC, Lim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Lee NY, Park YK, Bai GH, Koh WJ. Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. J Korean Med Sci. 2007. 22:677–681.
Article
16. Lee JH, Chang JH. Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. Korean J Intern Med. 2001. 16:173–179.
17. Kim SY, Jeong SS, Kim KW, Shin KS, Park SG, Kim AK, Cho HJ, Kim JO. Drug-resistant pulmonary tuberculosis in a tertiary referral hospital in Korea. Korean J Intern Med. 1999. 14:27–31.
18. Granich RM, Oh P, Lewis B, Porco TC, Flood J. Multidrug resistance among persons with tuberculosis in California, 1994-2003. JAMA. 2005. 293:2732–2739.
Article
19. Arevalo M, Solera J, Cebrian D, Bartolome J, Robles P. Risk factors associated with drug-resistant Mycobacterium tuberculosis in Castilla-la-Mancha (Spain). Eur Respir J. 1996. 9:274–278.
20. Chung MJ, Lee KS, Koh WJ, Kim TS, Kang EY, Kim SM, Kwon OJ, Kim S. Drug-sensitive tuberculosis, multidrug-resistant tuberculosis, and nontuberculous mycobacterial pulmonary disease in non-AIDS adults: comparisons of thin-section CT findings. Eur Radiol. 2006. 16:1934–1941.
Article